Related references
Note: Only part of the references are listed.Phase I clinical trial of oxaliplatin in children and adolescents with refractory solid tumors
Sheri L. Spunt et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors - A Pediatric Brain Tumor Consortium Study
Maryam Fouladi et al.
CANCER (2006)
Continuous or repeated prolonged cisplatin infusions in children:: A prospective study on ototoxicity, platinum concentrations, and standard serum parameters
C. Lanvers-Kaminsky et al.
PEDIATRIC BLOOD & CANCER (2006)
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
T Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A Randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
RM Goldberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Platinum compound-related ototoxicity in children - Long-term follow-up reveals continuous worsening of hearing loss
P Bertolini et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2004)
DNA strand breaks and apoptosis induced by oxaliplatin in cancer cells
S Faivre et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: Interim results of a phase III trial
ML Rothenberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Toxicity of platinum compounds
JT Hartmann et al.
EXPERT OPINION ON PHARMACOTHERAPY (2003)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
